Since 1923, we have been focused on innovation and leadership in diabetes care. Today we have a broad portfolio of medicines.
Since the launch of our first pen needle in 1985, we have been committed to enhancing injection experience by putting technology in patient hands.
Access information on our products for rare bleeding disorders, growth hormone-related disorders, and women's health.
Find information on our treatment for chronic weight management in adults who are overweight with one weight-related comorbidity or obesity.
The link above used in conjunction with the FDA-approved product labeling may be used to determine U.S. patents associated with the corresponding U.S. marketed product.
A place to find different points of view
from inside Novo Nordisk and the communities we serve.
Sharing a diabetes diagnosis with his father inspires a Novo Nordisk employee to better manage his T1D
Read Ian's story
One woman’s diabetes diagnosis led to a new career, love, and mentorship for the people around her
Read Stacey’s story
Read Lisa’s story
A Novo Nordisk employee takes the ride of a lifetime to support diabetes research
Read her story
Novo Nordisk employees support diabetes prevention and management in the Rosebud Sioux community
Read their stories
We celebrate 12 consecutive years on the list.
A Novo Nordisk employee and his family are changing lives in South Africa
An Olympic skier who lives with diabetes shares his story to inspire others.
A Novo Nordisk employee updated a family-favorite recipe for her grandmother with diabetes
Lisa uses the power she has as a mother to encourage her kids to give back
Watch her story